IXI Share PerformanceMore
|52 week high||38.000 29/12/17|
|52 week low||22.200 05/04/17|
|52 week change||-2.500 (-6.85%)|
|4 week volume||249,718 24/12/17|
Latest News« previous» nextMore
11/12/2017 - 07:18 StockMarketWire
IXICO saw robust revenue growth in the year to the end of September strengthened by the entry into a number of new co...
11/12/2017 - 07:00 RNS
RNS Number: 8804Y IXICO plc 11 December 2017 IXICO plc ("IXICO" or the "Company") Financial Results for the year ended 30 September 2017 Strong revenue growth and reduced operating losses as momentum builds IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces its final results for the year ended 30 September 201...
28/11/2017 - 07:00 RNS
RNS Number: 6555X IXICO plc 28 November 2017 28 November 2017 IXICO plc ("IXICO" or the "Company") Strategic and Operational Update Building scale and momentum with commercially-led growth Notice of Final Results IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today outlines its commercially led growth strategy as defin...
16/11/2017 - 08:20 StockMarketWire
IXICO has signed a new contract with another leading biopharmaceutical company to support the use of wrist worn activ...
16/11/2017 - 07:00 RNS
RNS Number: 6394W IXICO plc 16 November 2017 16 November 2017 IXICO plc ("IXICO" or the "Company") IXICO signs its first contract with a new biopharma customer to deploy biosensors in a late stage clinical trial for a psychiatric disorder Further expansion of IXICO's biopharma customer base and wearable biosensor technology IXICO plc (AIM: IXI), the dig...
19/10/2017 - 13:03 StockMarketWire
IXICO has reported revenue for the year ended 30 September of 3.7m (2016: 3.1m). The Company said the 0.6m increase over...
19/10/2017 - 09:14 RNS
RNS Number: 0775U IXICO plc 19 October 2017 19 October 2017 IXICO plc ("IXICO" or the "Company") Pre-Close Trading Update Double-digit revenue growth Three new contracts signed in September, including first wearables contract IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today provides the following pre-close trading update...
04/10/2017 - 06:49 StockMarketWire
IXICO has signed a new contract, with a top 15 global pharmaceutical company, utilising wrist worn activity sensors ('wear...
|Dividend yield||0 %|
Latest discussion posts More
“Very promising trading statement today........ 'double digit revenue growth'.. 'strong performance'.. 'ahead of expectations'.. '3 new contracts including first wearables'.. ...”▼
“Well, after the news this morning this all but disappeared down the toilet, but then the buyers moved in...... has some support after all. Been an interesting few weeks.”▼
“It would be nice to see 60p by the end of the week, now that it's got a little momentum. Pi”▼
Codes & Symbols
|Symbols||IXI, LSE:IXI, IXI.L, IXI:LN, LON:IXI, XLON:IXI|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment